1-4 of 4
Kristiina Vuori
Close
Sort by
Journal Articles

RNF5 Defines Acute Myeloid Leukemia Growth and Susceptibility to Histone Deacetylase Inhibitors

Ali Khateb, PhD, Anagha Deshpande, PhD, Yongmei Feng, PhD, Ikrame Lazar, PhD, Joo Sang Lee, PhD, Bertrand Fabre, PhD, Yan Li, PhD, Darren Finlay, PhD, Yu Fujita, PhD, Tongwu Zhang, PhD, Ian Pass, PhD, Ido Livneh, PhD, Carol Burian, James R. Mason, MD, Ronit Almog, MD, Nurit Horesh, MD, Yishai Ofran, MD, Kevin Brown, Kristiina Vuori, PhD, Michael Jackson, PhD, Eytan Ruppin, PhD, Aniruddha J. Deshpande, PhD, Ze'ev A. Ronai, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-143352
Published: 2020
Journal Articles

Optical Mapping Uncovers Multiple Novel Genomic Structural Variants in Patient Leukemias

Darren Finlay, PhD, Rabi Murad, Karl Hong, Joyce Lee, Andy Pang, PhD, Chi-Yu Lai, Carol Burian, James R. Mason, MD, Alex Hastie, PhD, Jun Yin, Kristiina Vuori, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
https://doi.org/10.1182/blood-2020-143175
Published: 2020
Journal Articles

Drug Sensitivity Across Acute Myeloid Leukemia Subtypes Using an in Vitro Assay

Levanto Schachter, DO, MSc, Irene M. Hutchins, MD, Jill Waalen, MD MPH, Carol Burian, CCRP, Darren Finlay, PhD, Kristiina Vuori, MD PhD, Giovanni Paternostro, MD PhD, Marin F. Xavier, MD, Carrie L. Costantini, MD, William E. Miller, MD, Jeffrey Andrey, MD, James Mason, MD
Journal: Blood
Blood (2016) 128 (22): 5208.
https://doi.org/10.1182/blood.V128.22.5208.5208
Published: 2016
Journal Articles

Engagement of the α2β1 integrin inhibits Fas ligand expression and activation-induced cell death in T cells in a focal adhesion kinase-dependent manner

Fawzi Aoudjit, Kristiina Vuori
Journal: Blood
Blood (2000) 95 (6): 2044–2051.
https://doi.org/10.1182/blood.V95.6.2044
Published: 2000